Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
I. Novakov (Plovdiv, Bulgaria), F. Sterev (Plovdiv, Bulgaria). Survival of patients with malignant pleural effusions: a three-year prospective self-experience study. 2890

Member's Comments

No comment yet.

Related content which might interest you: The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience. Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020 LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Parapneumonic effusions and empyema in childhood: a retrospective study Source: Eur Respir J 2003; 22: Suppl. 45, 319s Year: 2003 Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004 Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007 Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Pediatric pleural effusions: a retrospective review of 492 patients Source: Eur Respir J 2006; 28: Suppl. 50, 311s Year: 2006 Predictors of survival in patients with recurrent malignant pleural effusion Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008 Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinum Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Diagnostic value of medical thoracoscopy in pleural disease – a 5-year retrospective study Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008 Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012 Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009 Real life diagnosis in pleural effusion: a retrospective survey Source: Eur Respir J 2006; 28: Suppl. 50, 580s Year: 2006 Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019 A prospective study on etiology of haemorrhagic pleural effusion Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Resolution of tuberculosis pleural effusions following anti-tuberculosis treatment alone – a retrospective study Source: Eur Respir J 2007; 30: Suppl. 51, 419s Year: 2007